Clinical Trials · NCT02586831
Diabetes Islet Preservation Immune Treatment
- Phase
- Phase 1/Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Camillo Ricordi and Jay Skyler
- Enrollment
- 0
- Start date
- Jun 2024
- Locations
- See registry
- Primary endpoint
- Simulated C-peptide AUC